An undiagnosed case of placenta increta: a nightmare for obstetricians
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20223515Keywords:
Decidua basalis, Morbidly-adherent placenta, Placenta accrete spectrum disorder, ACUM, Nitabuch’s layerAbstract
Placenta increta, one type of morbidly adherent placenta, is characterized by entire or partial absence of the decidua basalis, and by the incomplete development of the fibrinoid or Nitabuch’s layer and villi actually invading the myometrium. The major clinical problem in placenta accreta spectrum disorder is failure of placenta to separate normally from the myometrium after fetal delivery. It is associated with high morbidity and sometimes with a lethal outcome, mainly as a result of severe bleeding, uterine rupture and infections. 33-year-old Mrs. X primigravida at 38 weeks 5 days admitted in our hospital for elective LSCS with the indication of hysteroscopy and laproscopic ACUM (accessory and cavitated uterine mass) excision in the past. Adherent placenta diagnosis was done on table, senior anesthetic team was called and decision was taken to remove the placenta manually with adequate resuscitative measures i/v/o torrential bleeding. Defect of 4×6 cm on the anterolateral part of the upper uterine segment (previous ACUM excision site). Decision was done to go ahead with vigilant watch, keeping ready for systematic devascularization of the uterus followed by caesarean hysterectomy in case torrential bleeding continues. With a multidisciplinary approach, Patient was serially monitored with USG, beta hCG levels, attempting to preserve uterus in this case. This was a very rare case of asymptomatic placenta previa with placenta increta in a post ACUM scarred uterus and it was successfully managed by sequential monitoring with backed up uterine embolization team if secondary PPH occurs.
Metrics
References
Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffmann BL, Casey BM, et al. Williams Obstetrics. 25th ed. New York, NY: McGraw Hill; 2018: 773- 782.
Hull, Andrew D., Resnik, Robert Md. Placenta Accreta and Postpartum Hemorrhage. Clin Obstet Gynecol. 2010;53(1):228-236.
Berchuck A, Sokol RJ. Previous cesarean section, placenta increta, and uterine rupture in second-trimester abortion. Am J Obstet Gynecol. 1983;145(6):766-7.
Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177(1):210-4.
Acién P, Acién M, Fernández F, José MM, Aranda I. The cavitated accessory uterine mass: a Müllerian anomaly in women with an otherwise normal uterus. Obstet Gynecol. 2010;116(5):1101-9.
Jain N, Verma R. Imaging diagnosis of accessory and cavitated uterine mass, a rare mullerian anomaly. Indian J Radiol Imaging. 2014;24(2):178-81.
Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accreta--summary of 10 years: a survey of 310 cases. Placenta. 2002;23(2-3):210-4.
Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med. 1992;11(7):333-43.
Lam G, Kuller J, McMahon M. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. J Soc Gynecol Investig. 2002;9(1):37-40.
Haynes DI, Smith JH, Fothergill DJ. A case of placenta increta presenting in the first trimester. J Obstet Gynaecol. 2000;20(4):434-5.
Fox H. Placenta accreta, 1945-1969. Obstet Gynecol Surv. 1972;27:475.
Crespo R, Lapresta M, Madani B. Conservative treatment of placenta increta with methotrexate. Int J Gynaecol Obstet. 2005;91(2):162-3.
Kayem G, Davy C, Goffinet F, Thomas C, Clément D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol. 2004;104(3):531-6.
Liao CY, Ding DC. Failure of conservative treatment for placenta increta. Taiwan J Obstet Gynecol. 2009;48(3):302-4.